arrow
V

Vic E. Myer

nchromabio
H指数:32
被引数:2.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Development of an investigational epigenetic silencer therapy to transcriptionally inactivate viral DNA in chronic hepatitis B

开发一种研究性表观遗传沉默疗法以转录失活慢性乙型肝炎病毒DNA

2026-09-210
OAAI
A potent epigenetic editor targeting human PCSK9 for durable reduction of low-density lipoprotein cholesterol levels

一种靶向人PCSK9的强效表观遗传编辑器,用于持久降低低密度脂蛋白胆固醇水平

2025-02-103
OA
AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines (vol 12, 3908, 2021)
2021-07-193
OAAI
AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines

AsCas12a超核酸酶促进治疗细胞药物的快速生成

2021-06-2377
OAAI
Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10
2019-01-21512
PREAI
Unexpected mutations after CRISPR-Cas9 editing in vivo
2018-03-3022
PREAI
SMN2 splice modulators enhance U1-pre-mRNA association and rescue SMA mice (vol 11, pg 511, 2015)
2016-03-182
OAAI
SMN2 splice modulators enhance U1-pre-mRNA association and rescue SMA mice (vol 11, pg 511, 2015)
2015-08-184
OAAI
SMN2 splice modulators enhance U1-pre-mRNA association and rescue SMA mice
2015-06-01375
PREAI
Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo

选择性VPS34抑制剂阻断自噬并揭示NCOA4在体内铁蛋白降解和铁稳态中的作用

2014-10-19606
PREAI
Target identification for a Hedgehog pathway inhibitor reveals the receptor GPR39
2014-03-1656
PREAI
Functional epigenetics approach identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancers
2014-02-11355
OAAI
A functional screen of the epigenome identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancers
2013-11-010
PRE